statement
Based on current experimental data, the targets of the three pipelines are relatively clear and have a certain probability of becoming drugs.
A statement by 昂利康. Statements are as reported by the cited publishers — not verified by DecisionGateway.
從目前的實驗數據來看,三條管線靶點相對明確,具備一定成藥的概率
Discussion
Related claims
Three pipelines are currently at the preclinical PCC stage and are progressing as planned.昂利康 · statementThere are currently no plans to set another three-year target, but non-cash payments will continue to be promoted and whether to set a new target can be discussed later.王允中 · statementGoing from PCC to IND requires completing candidate molecule confirmation, pharmaceutical and non-clinical research work.昂利康 · statementDATAPATTNS has a target of 4291.3.MOSt Overnight · predictionLY03017 for psychotic disorders associated with Alzheimer's disease has entered Phase II clinical trials in China and completed first dosing; LY03020, as the world's first TAAR1/5-HT2CR dual-target agonist, also lists psychotic disorders associated with Alzheimer's disease as a target indication.post author · statementThe announcement explicitly states that no similar drug has been approved for marketing domestically or abroad.公告 · statement
More claims by 昂利康
Under normal circumstances, the process takes about 1 to 1.5 years.predictionThe overall cycle is heavily influenced by the technical route and experimental results.statementThe production timeline for the self-ionizable lipids will also be tied to 科瑞生物's R&D and production progress.statementGoing from PCC to IND requires completing candidate molecule confirmation, pharmaceutical and non-clinical research work.statementThree pipelines are currently at the preclinical PCC stage and are progressing as planned.statement
All claims by 昂利康